Filing Details

Accession Number:
0001209191-15-038091
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-01 17:42:17
Reporting Period:
2015-04-29
Filing Date:
2015-05-01
Accepted Time:
2015-05-01 17:42:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142596 Nuvasive Inc NUVA Surgical & Medical Instruments & Apparatus (3841) 330768598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565985 Russell Powers 7475 Lusk Blvd.
San Diego CA 92121
Evp, International No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-04-29 9,471 $45.40 73,482 No 4 S Direct
Common Stock Acquisiton 2015-05-01 4,016 $26.62 77,498 No 4 M Direct
Common Stock Disposition 2015-05-01 2,410 $44.44 75,088 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2015-05-01 4,016 $0.00 4,016 $26.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-01-03 No 4 M Direct
Footnotes
  1. Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2015, which is intended to comply with Rule 10b5-1.
  2. Weighted average from 2 transactions with prices of $45.000 and $46.620. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  3. Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
  4. Sale of shares to cover the exercise price of the underlying stock option. Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on March 10, 2015, which is intended to comply with Rule 10b5-1.
  5. Weighted average from 12 transactions with prices ranging from $44.3900 to $44.5000. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  6. The option, representing a right to purchase a total of 2,234 shares, became exercisable as follows: 25% of the shares vested on January 3, 2012; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2015, subject to continued employment through each vesting period.